Sedana Medical AB (FRA:7D2A) Total Equity: €81.04 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:7D2A Sedana Medical AB FRA:7D2A
69 GF Score
Price €0.86
GF Value €1.47
! 2 Warning Signs
View Full Analysis

What is Sedana Medical AB Total Equity?

Sedana Medical AB FRA:7D2A +3.63% 69 Total Equity is €81.04 Mil as of Jun. 2026. GuruFocus rates FRA:7D2A with a GF Score™ of 69/100 and a GF Value™ of €1.47. The stock has 2 warning signs investors should review.

Sedana Medical AB's total equity for the quarter that ended in Jun. 2026 was €81.04 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.

Sedana Medical AB Total Equity Historical Data

* Premium members only.

The historical data trend for Sedana Medical AB's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sedana Medical AB Total Equity Chart

Sedana Medical AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 107.24 93.61 86.72 83.31 82.78

Sedana Medical AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 83.56 82.58 82.78 83.36 81.04
FRA:7D2A
69GF Score
Sedana Medical AB FRA:7D2A
Total Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sedana Medical AB Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

Sedana Medical AB's Total Equity for the fiscal year that ended in Dec. 2025 is calculated as

Total Equity=Total Assets(Q: Dec. 2025 )-Total Liabilities(Q: Dec. 2025 )
=87.708-4.933
=82.78

Sedana Medical AB's Total Equity for the quarter that ended in Jun. 2026 is calculated as

Total Equity=Total Assets(Q: Jun. 2026 )-Total Liabilities(Q: Jun. 2026 )
=85.519-4.475
=81.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Equity →
What does a Total Equity of €81.04 Mil mean?
Sedana Medical AB (FRA:7D2A) has a Total Equity of €81.04 Mil as of Jun. 2026. The total amount of equity as record on a company's balance sheet. View historical data for Sedana Medical AB and its competitors.
Is Sedana Medical AB's Total Equity too high?
Sedana Medical AB's current Total Equity is €81.04 Mil. Overall, Sedana Medical AB has a GF Score™ of 69/100, reflecting its overall financial health beyond just this single metric.
How does Sedana Medical AB's Total Equity compare to ABT and SYK?
Sedana Medical AB's Total Equity of €81.04 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Equity for a Medical Devices & Instruments company?
A good Total Equity depends on the Medical Devices & Instruments industry context. However, Total Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Equity mean?
A high Total Equity can signal that a stock is expensive relative to its fundamentals. The total amount of equity as record on a company's balance sheet. View historical data for Sedana Medical AB and its competitors. Sedana Medical AB's current Total Equity is €81.04 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sedana Medical AB stock overvalued right now?
Sedana Medical AB (FRA:7D2A) has a current Total Equity of €81.04 Mil. The stock's GF Value™ is €1.47, compared to a current price of €0.86 — trading 41.7% below its estimated fair value. The current Total Equity is €81.04 Mil. Sedana Medical AB's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Equity calculated?
Total Equity is calculated from a company's financial statements. For Sedana Medical AB (FRA:7D2A), the current Total Equity is €81.04 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sedana Medical AB (FRA:7D2A) Overvalued in 2026?

Based on GuruFocus' analysis, Sedana Medical AB stock appears to be undervalued. The current stock price of €0.86 is trading 41.7% below its estimated GF Value™ of €1.47.

Key valuation signals for FRA:7D2A:

  • Total Equity: €81.04 Mil
  • GF Value™: €1.47 vs. price of €0.86 (41.7% below fair value)
  • GF Score™: 69/100 with 2 warning signs

No single metric tells the full story. See the FRA:7D2A stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sedana Medical AB Business Description

Other Exchanges SEDANA:Sweden
Address Svardvagen 3A, Danderyd, SWE, SE-182 33
Sedana Medical AB is a Sweden-based medical technology company. It is ais a pioneer medtech and pharmaceutical company focused on inhaled sedation to improve the patient's life during and beyond sedation. Through the combined strengths of the medical device Sedaconda ACD and the pharmaceutical Sedaconda (isoflurane), Sedana Medical provides inhaled sedation for mechanically ventilated patients in intensive care. Sedana Medical has direct sales in Benelux, France, Germany, Great Britain, and Spain. In other parts of Europe, as well as in Asia, Australia, Canada, and South and Central America, the company works with external distributors.
69GF Score

Get the complete analysis for FRA:7D2A

Total Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.86
Price
€1.47
GF Value